Global Beef Genomic Testing Service Market Strategic Research Report
By Type: Genotic Chip Array, Whole Genome Resequencing, Targeted Sequencing Genotyping
By Application: Breeding Farm, Fattening Farm, Processing Plant, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Genus plc (LSE: GNS, Basingstoke UK), Zoetis Inc. (NYSE: ZTS, New Jersey USA), Neogen Corporation (NASDAQ: NEOG, Michigan USA), Delta Genomics (Unlisted, Alberta Canada), VHL Genetics (Unlisted, Wageningen Netherlands), CD Genomics (Unlisted, New York USA), Novogene Co., Ltd. (SSE: 688315, Beijing China), BGI Group (Unlisted, Shenzhen China), Higentec Co., Ltd. (Unlisted, Changsha China), Beijing Compass Biotechnology Co., Ltd. (Unlisted, Beijing China), MolBreeding Biotechnology Co., Ltd. (Unlisted, Hebei China)
Overview
Scope of the Report
The global Beef Genomic Testing Service market size is predicted to grow from US$ 6,848 million in 2025 to US$ 9,711 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.
Beef genomic testing service is a professional service that use gene sequencing and microarray technology to scan and analyze the entire genome or key gene loci of individual beef cattle. Its core function is to transform invisible genetic potential into quantifiable breeding data, solving the fundamental problems of traditional beef cattle breeding, such as long phenotypic selection cycles, low efficiency, and the inability to accurately predict breeding performance, disease risk, and offspring genetic value in the early stages. This represents a leap from "experience-based breeding" to "precision breeding." Upstream are technology, equipment, and data providers, including gene sequencer and microarray manufacturers, bioinformatics software companies, and global beef cattle genotype and phenotypic databases. Downstream, it directly serves core participants in the beef cattle industry, primarily including: 1. Breeding farms (for selecting top-performing bulls and core cows); 2. Commercial fattening farms (for screening high-performance feeder cattle and optimizing fattening herds); 3. Slaughtering and processing enterprises and brand owners (for tracing the genetic origin of meat, ensuring consistent meat quality, and brand marketing). In 2025, the average price of beef genomic testing service was approximately US$120 per head, with a gross profit margin of approximately 45%.
Global key Beef Genomic Testing Service players cover Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Genus plc (LSE: GNS, Basingstoke UK), Zoetis Inc. (NYSE: ZTS, New Jersey USA), Neogen Corporation (NASDAQ: NEOG, Michigan USA), etc.
This report presents a comprehensive overview of the global Beef Genomic Testing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Genotic Chip Array
- Whole Genome Resequencing
- Targeted Sequencing Genotyping
Segment by Detection Purpose
- Production Trait Evaluation
- Reproduction and Health Trait Evaluation
- Breed Purity and Composition Analysis
Segment by Application
- Breeding Farm
- Fattening Farm
- Processing Plant
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Beef Genomic Testing Service market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Breeding Farm, Fattening Farm, Processing Plant evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Beef Genomic Testing Service Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Genotic Chip Array
- 3.1.3 Whole Genome Resequencing
- 3.1.4 Targeted Sequencing Genotyping
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Breeding Farm
- 4.1.3 Fattening Farm
- 4.1.4 Processing Plant
- 4.1.5 Other
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Illumina, Inc. (NASDAQ: ILMN, California USA)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Genus plc (LSE: GNS, Basingstoke UK)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Zoetis Inc. (NYSE: ZTS, New Jersey USA)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Neogen Corporation (NASDAQ: NEOG, Michigan USA)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Delta Genomics (Unlisted, Alberta Canada)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 VHL Genetics (Unlisted, Wageningen Netherlands)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 CD Genomics (Unlisted, New York USA)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Novogene Co., Ltd. (SSE: 688315, Beijing China)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 BGI Group (Unlisted, Shenzhen China)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Higentec Co.,Ltd. (Unlisted, Changsha China)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Beijing Compass Biotechnology Co., Ltd. (Unlisted, Beijing China)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 MolBreeding Biotechnology Co., Ltd. (Unlisted, Hebei China)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Beef Genomic Testing Service market?
How fast is the Beef Genomic Testing Service market expected to grow?
What does the Beef Genomic Testing Service market cover?
How is the Beef Genomic Testing Service market segmented by type?
What are the key applications of Beef Genomic Testing Service?
Which companies are profiled in the Beef Genomic Testing Service market report?
What geographies does the Beef Genomic Testing Service market analysis include?
Who should buy the Beef Genomic Testing Service market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Beef Genomic Testing Service Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Biotechnology & Life Sciences